Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Selected Risk Nutritional Factors for Chemotherapy-Induced Polyneuropathy

J. Grim, A. Ticha, R. Hyspler, M. Valis, Z. Zadak,

. 2017 ; 9 (6) : . [pub] 20170525

Language English Country Switzerland

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc18010510

The present study seeks to identify the nutritional risk factors involved in the development of neuropathies induced by chemotherapeutic treatments. Unlike the gastrointestinal or hematological adverse effects of chemotherapy there is no protective treatment strategy for polyneuropathy. The aim of this study was to find possible deficiencies in nutritional factors, which can be used for supplementation in the future for prevention of chemotherapy-induced neuropathy development. We analyzed 70 patients undergoing paclitaxel chemotherapy and evaluated the risk factors involved in chemotherapy-induced peripheral neuropathy (CIPN). Several risk factors were considered in the development of CIPN, including deficiency of vitamin B1, B6, and D and fatty acids. The occurrence of CIPN complication in 60% cases was observed. We found significant differences in vitamin D and saturated fatty acid concentration. Vitamin D levels in the group without CIPN were estimated to be 38.2 (24.95, 47.63) nmol/L, whereas in the group with CIPN it was determined to be 25.6 (19.7, 32.55) nmol/L,p= 0.008. The level of total saturated fatty acids in the group without CIPN was of 32.613 Area % (31.322; 36.262), whereas in the group with CIPN it was of 34.209 Area % (32.86; 39.386),p= 0.01. The obtained results suggest a diet lower in saturated fatty acid content during chemotherapy. The most significant finding was that supplementation of vitamin D before chemotherapy could be an efficient neuroprotective in CIPN prophylaxis, as significantly lower levels 25OH derivative of vitamin D were observed in the CIPN group throughout the study period.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18010510
003      
CZ-PrNML
005      
20180426140041.0
007      
ta
008      
180404s2017 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/nu9060535 $2 doi
035    __
$a (PubMed)28587059
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Grim, Jiri $u Department of Oncology and Radiotherapy, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech. grimj@lfhk.cuni.cz.
245    10
$a Selected Risk Nutritional Factors for Chemotherapy-Induced Polyneuropathy / $c J. Grim, A. Ticha, R. Hyspler, M. Valis, Z. Zadak,
520    9_
$a The present study seeks to identify the nutritional risk factors involved in the development of neuropathies induced by chemotherapeutic treatments. Unlike the gastrointestinal or hematological adverse effects of chemotherapy there is no protective treatment strategy for polyneuropathy. The aim of this study was to find possible deficiencies in nutritional factors, which can be used for supplementation in the future for prevention of chemotherapy-induced neuropathy development. We analyzed 70 patients undergoing paclitaxel chemotherapy and evaluated the risk factors involved in chemotherapy-induced peripheral neuropathy (CIPN). Several risk factors were considered in the development of CIPN, including deficiency of vitamin B1, B6, and D and fatty acids. The occurrence of CIPN complication in 60% cases was observed. We found significant differences in vitamin D and saturated fatty acid concentration. Vitamin D levels in the group without CIPN were estimated to be 38.2 (24.95, 47.63) nmol/L, whereas in the group with CIPN it was determined to be 25.6 (19.7, 32.55) nmol/L,p= 0.008. The level of total saturated fatty acids in the group without CIPN was of 32.613 Area % (31.322; 36.262), whereas in the group with CIPN it was of 34.209 Area % (32.86; 39.386),p= 0.01. The obtained results suggest a diet lower in saturated fatty acid content during chemotherapy. The most significant finding was that supplementation of vitamin D before chemotherapy could be an efficient neuroprotective in CIPN prophylaxis, as significantly lower levels 25OH derivative of vitamin D were observed in the CIPN group throughout the study period.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a protinádorové látky $x škodlivé účinky $7 D000970
650    _2
$a mastné kyseliny $7 D005227
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a nutriční stav $7 D009752
650    _2
$a polyneuropatie $x chemicky indukované $7 D011115
650    _2
$a rizikové faktory $7 D012307
650    _2
$a vitamin D $x krev $7 D014807
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ticha, Alena $u Department of Research and Development, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech. alena.ticha@fnhk.cz. Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech. alena.ticha@fnhk.cz.
700    1_
$a Hyspler, Radomir $u Department of Research and Development, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech. rhyspler@lfhk.cuni.cz. Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech. rhyspler@lfhk.cuni.cz.
700    1_
$a Valis, Martin $u Department of Neurology, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech. martin.valis@fnhk.cz.
700    1_
$a Zadak, Zdenek $u Department of Research and Development, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech. zdenek.zadak@fnhk.cz.
773    0_
$w MED00189563 $t Nutrients $x 2072-6643 $g Roč. 9, č. 6 (2017)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28587059 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180426140152 $b ABA008
999    __
$a ok $b bmc $g 1287995 $s 1007322
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 9 $c 6 $e 20170525 $i 2072-6643 $m Nutrients $n Nutrients $x MED00189563
LZP    __
$a Pubmed-20180404

Find record

Citation metrics

Archiving options